Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Isobutylmethylxanthine(IBMX) Market by Type (Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%), By Application (Research, Biopharmaceutical) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Isobutylmethylxanthine(IBMX) Market by Type (Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%), By Application (Research, Biopharmaceutical) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 361514 4200 Chemical & Material 377 139 Pages 4.9 (33)
                                          

Market Overview:


The market growth can be attributed to the increasing demand for IBMX in research and biopharmaceutical applications. IBMX is used as a pharmacological agent for its xanthine properties and has been found to possess anti-inflammatory, analgesic, and bronchodilatory effects. It also helps in the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders. North America dominates the global IBMX market due to the presence of key players operating in this region and rising R&D expenditure by pharmaceutical companies on novel drug discovery programs.


Global Isobutylmethylxanthine(IBMX) Industry Outlook


Product Definition:


It has been used to study the role of cyclic AMP in various cellular processes.


Min Purity Less Than 98%:


It’s an organic compound that is soluble in water and slightly soluble in alcohol. The chemical formula for IBMX is (CH3)2N(C4H9)S and it has a molecular weight of 132.2.


Min Purity 98%-99%:


Min Purity 98%-99% is a product that contains very low impurities of Isobutyl methyl xanthine. It is used in the pharmaceutical industry as an intermediate for manufacturing various medicines such as erythropoietin, warfarin, and insulin. The growing demand for these products from the pharmaceutical industry has been driving the market growth over the past few years.


The other applications include use in research laboratories studying drug metabolism.


Application Insights:


Various research studies have proved that IsoBmx acts as a cerebral vasodilator, improves learning and memory in mice, rats and rabbits, reduces blood pressure among obese animals, prevents atherosclerosis by inhibiting lipid peroxidation and down-regulating expression of adhesion molecules such as ICAM-1 & VCAM-1 which are involved in plaque formation.


However, pharmaceutical application for isobutyl methyl xanthine will witness the fastest growth rate over the forecast period owing to rising incidences of sleep disorders like insomnia among adults worldwide coupled with growing awareness about mental health issues especially depression during daytime amongst working professionals.


Regional Analysis:


North America dominated the global market in 2017. The region is expected to witness a growth rate of 5.6% over the forecast period, owing to rising product consumption as a result of increased research activities and presence of major companies in this region. Asia Pacific is anticipated to be one of the fastest-growing regions during the same period on account of increasing health awareness among people and rising disposable income levels coupled with government support for higher education and medical research activities.


Growth Factors:


  • Increasing demand from the food and beverage industry as a flavor enhancer and preservative
  • Growing popularity of energy drinks and dietary supplements that contain IBMX
  • Increased research on the potential health benefits of IBMX, including weight loss and cognitive enhancement
  • Development of new applications for IBMX in cosmetics, pharmaceuticals, and other industries
  • Expansion of manufacturing capacity to meet rising demand

Scope Of The Report

Report Attributes

Report Details

Report Title

Isobutylmethylxanthine(IBMX) Market Research Report

By Type

Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%

By Application

Research, Biopharmaceutical

By Companies

Thermo Fisher Scientific, Abcam, Merck, Cayman Chemical, Santa Cruz Biotechnology, BioVision, Focus Biomolecules, STEMCELL Technologies, Selleck Chemicals, BPS Bioscience, Enzo Biochem, Adipogen Life Sciences, AbMole BioScience, Cell Signaling Technology, Beyotime, Shanghai Maokang Biotechnology

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

139

Number of Tables & Figures

98

Customization Available

Yes, the report can be customized as per your need.


Global Isobutylmethylxanthine(IBMX) Market Report Segments:

The global Isobutylmethylxanthine(IBMX) market is segmented on the basis of:

Types

Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Research, Biopharmaceutical

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Thermo Fisher Scientific
  2. Abcam
  3. Merck
  4. Cayman Chemical
  5. Santa Cruz Biotechnology
  6. BioVision
  7. Focus Biomolecules
  8. STEMCELL Technologies
  9. Selleck Chemicals
  10. BPS Bioscience
  11. Enzo Biochem
  12. Adipogen Life Sciences
  13. AbMole BioScience
  14. Cell Signaling Technology
  15. Beyotime
  16. Shanghai Maokang Biotechnology

Global Isobutylmethylxanthine(IBMX) Market Overview


Highlights of The Isobutylmethylxanthine(IBMX) Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Min Purity Less Than 98%
    2. Min Purity 98%-99%
    3. Min Purity More Than 99%
  1. By Application:

    1. Research
    2. Biopharmaceutical
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Isobutylmethylxanthine(IBMX) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Isobutylmethylxanthine(IBMX) Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Isobutylmethylxanthine is a stimulant drug that is used to improve mental focus and concentration.

Some of the major players in the isobutylmethylxanthine(ibmx) market are Thermo Fisher Scientific, Abcam, Merck, Cayman Chemical, Santa Cruz Biotechnology, BioVision, Focus Biomolecules, STEMCELL Technologies, Selleck Chemicals, BPS Bioscience, Enzo Biochem, Adipogen Life Sciences, AbMole BioScience, Cell Signaling Technology, Beyotime, Shanghai Maokang Biotechnology.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Isobutylmethylxanthine(IBMX) Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Isobutylmethylxanthine(IBMX) Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Isobutylmethylxanthine(IBMX) Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Isobutylmethylxanthine(IBMX) Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Isobutylmethylxanthine(IBMX) Market Size & Forecast, 2020-2028       4.5.1 Isobutylmethylxanthine(IBMX) Market Size and Y-o-Y Growth       4.5.2 Isobutylmethylxanthine(IBMX) Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Min Purity Less Than 98%
      5.2.2 Min Purity 98%-99%
      5.2.3 Min Purity More Than 99%
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Research
      6.2.2 Biopharmaceutical
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Isobutylmethylxanthine(IBMX) Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Isobutylmethylxanthine(IBMX) Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Min Purity Less Than 98%
      9.6.2 Min Purity 98%-99%
      9.6.3 Min Purity More Than 99%
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Research
      9.10.2 Biopharmaceutical
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Min Purity Less Than 98%
      10.6.2 Min Purity 98%-99%
      10.6.3 Min Purity More Than 99%
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Research
      10.10.2 Biopharmaceutical
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Min Purity Less Than 98%
      11.6.2 Min Purity 98%-99%
      11.6.3 Min Purity More Than 99%
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Research
      11.10.2 Biopharmaceutical
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Min Purity Less Than 98%
      12.6.2 Min Purity 98%-99%
      12.6.3 Min Purity More Than 99%
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Research
      12.10.2 Biopharmaceutical
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Min Purity Less Than 98%
      13.6.2 Min Purity 98%-99%
      13.6.3 Min Purity More Than 99%
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Research
      13.10.2 Biopharmaceutical
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Isobutylmethylxanthine(IBMX) Market: Competitive Dashboard
   14.2 Global Isobutylmethylxanthine(IBMX) Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Thermo Fisher Scientific
      14.3.2 Abcam
      14.3.3 Merck
      14.3.4 Cayman Chemical
      14.3.5 Santa Cruz Biotechnology
      14.3.6 BioVision
      14.3.7 Focus Biomolecules
      14.3.8 STEMCELL Technologies
      14.3.9 Selleck Chemicals
      14.3.10 BPS Bioscience
      14.3.11 Enzo Biochem
      14.3.12 Adipogen Life Sciences
      14.3.13 AbMole BioScience
      14.3.14 Cell Signaling Technology
      14.3.15 Beyotime
      14.3.16 Shanghai Maokang Biotechnology

Our Trusted Clients

Contact Us